共 68 条
[1]
Spaide RF(2006)Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration Retina 26 383-390
[2]
Laud K(2007)Infectious and noninfectious endophthalmitis after intravitreal bevacizumab J Ocular Pharmacol Ther 23 240-242
[3]
Fine HF(2007)Endophthalmitis associated with intravitreal injections Int Ophthalmol Clin 47 199-208
[4]
Klancnik JM(2006)MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419-1431
[5]
Meyerle CB(2003)Acute endophthalmitis following intravitreal triamcinolone acetonide injection Am J Ophthalmol 136 791-796
[6]
Yannuzzi LA(2007)Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis Am J Ophth 144 50-54
[7]
Sorenson J(2006)Case of anterior uveitis after intravitreal injection of bevacizumab Retina 26 841-842
[8]
Slakter J(2005)Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration Ophthalmology 112 1048-1053
[9]
Fisher YL(2003)Noninfectious endophthalmitis associated with intravitreal triamcinolone injection Arch Ophthalmol 121 1279-1282
[10]
Cooney MJ(2006)Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab Retina 26 877-881